ClearPoint Neuro (NASDAQ:CLPT) is a medical device company specializing in the development and commercialization of real-time magnetic resonance imaging (MRI)-guided technologies for neurosurgical procedures. The company’s core offering, the ClearPoint® Neuro Navigation and Delivery System, enables neurosurgeons to perform minimally invasive procedures with high precision by integrating live MRI feedback during therapy delivery. This platform supports a range of intracranial interventions, including deep brain stimulation lead placement, laser ablation, and targeted drug delivery, with the goal of improving surgical accuracy and patient outcomes.
In addition to its flagship navigation system, ClearPoint Neuro offers SmartFlow™ infusion catheters designed for controlled and uniform distribution of therapeutic agents into brain tissue. These catheters address challenges associated with conventional infusion techniques by reducing reflux and ensuring consistent drug delivery. Together, the navigation system and infusion technology form an integrated approach to treating neurological disorders such as movement disorders, tumors, and epilepsy.
Headquartered in Redwood City, California, ClearPoint Neuro markets its products primarily in the United States and has begun expanding into select European and Asian markets. The company collaborates with leading academic medical centers and research institutions to advance the clinical use of MRI-guided procedures. Through partnerships with neurosurgeons and neurologists, ClearPoint Neuro continues to refine its platform and explore new indications, including gene and cell therapies for central nervous system diseases.
Since its founding, ClearPoint Neuro has been led by a management team with deep expertise in medical device development, radiology and neurosurgery. Guided by a board that includes experienced clinicians and industry veterans, the company remains focused on innovation, regulatory excellence and building a comprehensive portfolio of image-guided solutions. ClearPoint Neuro’s mission is to enable safer, more effective brain therapies and to support the next generation of neurological treatments worldwide.
